Purchase this article with an account.
Ilana Forchheimer, A. John Kanellopoulos; Evaluation Of Toric IOL Implantation In Cataract Surgery. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6673.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the safety, efficacy and clinical parameters of the Acrysof Toric, IOL (Alcon, Fort Worth, TX) in cataract surgery
115 eyes of 78 consecutive patients were evaluated pre-operatively and 6 months post-operatively for the following: age, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), manifest refraction, cylinder (C), topographic cylinder change (TCc), corneal endothelial cell count (ECC), degrees of deviation from planned to achieved IOL axis (Ad), and possible complications.
The mean age of the patients included was 67 years. The average pre-operative and post-operative visual acuities respectively were 20/100 and 20/25 (UCVA) and 20/40 and 20/22 (BCVA). The average spherical equivalent was reduced from from 4.2 to 0.5 diopters and the average cylinder was reduced from -2.75 diopters to -0.55 diopters. The mean TCc was -0.45. The average pre-operative and post-operative ECC respectively was 1850 and 1650. The average Ad was 5 degrees. No complications were encountered in this small group.
This novel IOL appears to be safe and effective in facilitating emmetropia in routine cataract surgery.
This PDF is available to Subscribers Only